12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, 12 health care stocks experienced significant price movements. Aclarion, China Pharma Holding, Evaxion Biotech, NanoVibronix, MSP Recovery, and 4D Molecular Therapeutics saw gains, while Precipio, BiomX, Landos Biopharma, PolarityTE, Akoya Biosciences, and Werewolf Therapeutics experienced losses.
June 08, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aclarion's stock increased by 38.5% to $1.44 during Thursday's pre-market session, with a market cap of $11.3 million.
Aclarion's stock price increased significantly during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
China Pharma Holding's stock moved upwards by 13.22% to $0.45, with a market cap of $4.3 million.
China Pharma Holding's stock price increased during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Evaxion Biotech's shares rose 13.04% to $1.56, with a market value of $41.2 million.
Evaxion Biotech's stock price increased during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
4D Molecular Therapeutics' shares increased by 12.2% to $20.5, with a market value of $858.1 million.
4D Molecular Therapeutics' stock price increased during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
MSP Recovery's shares rose 12.45% to $0.54, with a market cap of $39.8 million.
MSP Recovery's stock price increased during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
NanoVibronix's stock moved upwards by 12.87% to $3.92, with a market cap of $6.5 million.
NanoVibronix's stock price increased during the pre-market session, indicating positive investor sentiment and potential for further gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Akoya Biosciences' shares fell 9.0% to $5.06, with a market cap of $194.3 million.
Akoya Biosciences' stock price decreased during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Werewolf Therapeutics' stock declined by 7.98% to $3.11, with a market value of $110.7 million.
Werewolf Therapeutics' stock price decreased during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Landos Biopharma's shares declined by 9.79% to $3.19, with a market cap of $9.9 million.
Landos Biopharma's stock price decreased during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
BiomX's stock decreased by 11.4% to $0.32, with a market cap of $14.5 million.
BiomX's stock price decreased during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Precipio's shares decreased by 26.5% to $0.5, with a market value of $11.7 million.
Precipio's stock price decreased significantly during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
PolarityTE's shares decreased by 9.59% to $0.26, with a market cap of $1.9 million.
PolarityTE's stock price decreased during the pre-market session, indicating negative investor sentiment and potential for further losses in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100